Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for JAV stock. Download JAV report.
Research Report
Get the full report for FREE
Date:Aug 13, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download JAV report
  
Example preview: Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV)
   

Cash Flow for Javelin Pharmaceuticals, Inc (JAV)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Symbol:  | Recent Quotes powered by
  quotemedia.com
Cash Flow for Javelin Pharmaceuticals Inc  (JAV) 
$ 1.47   0.07 (+5.00%) Volume: 319.22 k 4:00 PM EST Nov 20, 2009
After Hours:  $ 1.59   0.12 (+8.16%) Volume: 4.0 k 4:22 PM EST Nov 20, 2009
Statement: View:
Cash Flow in Thousands of Dollars
12/2008 12/2007 12/2006 12/2005 12/2004
Net Income (43,463) (31,031) (17,798) (10,612) (7,047)
Depreciation & Amortization 294 98 61 44 32
Deferred Income Taxes - - - - -
Operating Losses - - - 747 646
Extraordinary Losses - - - - -
Decrease in Receivables - 114 460 (458) 60
Decrease in Inventories (1,732) (116) - - -
Decrease in Other Current Assets - - - - -
Increase in Payables 1,973 3,007 1,944 (1,089) 1,306
Increase in Other Current Liabilities 29 426 28 12 7
Decrease in Other Working Capital - - - - 500
Other Non-Cash Items 3,513 3,460 2,823 - -
Net Cash from Continuing Operations (38,771) (25,130) (12,477) (11,286) (4,458)
Net Cash from Discontinued Operations - - - - -
Cash from Operating Activities (38,771) (25,130) (12,477) (11,286) (4,458)
Sale of Property, Plant, Equipment - - - - -
Sale of Short Term Investments 21,652 47,560 11,820 - -
Purchase of Property, Plant, Equipment (943) (406) (136) (69) (119)
Acquisitions (2,000) (1,800) - - -
Purchase of Short Term Investments (2,100) (57,401) (23,251) - -
Other Investment Changes, Net - - - - -
Cash from Investing Activities 16,609 (12,047) (11,567) (69) (119)
Issuance of Debt - - - - 1,000
Issuance of Capital Stock 28,057 47,333 10 32,105 18,087
Repayment of Debt - - - - (1,000)
Repurchase of Capital Stock - - - - -
Payment of Cash Dividends - - - - -
Other Financing Charges, Net (1,768) (3,498) - (2,225) (1,878)
Cash from Financing Activities 26,289 43,835 10 29,879 16,208
Effect of Exchange Rate Changes - - - - -
Net Change in Cash 4,127 6,658 (24,034) 18,524 11,632
Cash at Beginning of Year 15,931 9,273 33,307 14,783 3,151
Cash at End of Period 20,058 15,931 9,273 33,307 14,783

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, financials by Morningstar.  Terms of Use. 
   
 
Home > Companies > Javelin Pharmaceuticals, Inc